Pakistan gives go-ahead to Phase 3 COVID-19 vaccine trial
ISLAMABAD – Pakistan’s drug regulator greenlit the country’s first Phase 3 clinical trial for a potential COVID-19 vaccine, which is being developed by China’s CanSino Biologics (CanSino) and Beijing Institute of Biotechnology. The trial is slated to begin next month, according to an official who will coordinate the […]



